Dr. Guillermo Ameer, Daniel Hale Williams Professor of Biomedical Engineering and Surgery at Northwestern University, is creating a set of high-tech tools to manage diverse medical conditions. Dr. Ameer directs the Center for Advanced Regenerative Engineering (CARE) which integrates and supports research, technology development, and clinical expertise to improve the outcome of tissue and organ repair and regeneration for adult and pediatric patients. Dr. Ameer’s lab develops biomaterials and nanotechnology for regenerative engineering, tissue engineering, medical devices, drug delivery, and cell delivery applications. In the lab, projects driving the creation and engineering of novel biomaterials to target and treat vascular, endocrine, and bone pathophysiologies are on deck. Dr. Ameer has co-authored over 200 peer-reviewed journal publications and conference abstracts, several book chapters, and multiple patents issued and pending (>35). He has founded 3 companies: ProSorp Biotech, VesselTek Biomedical and Citrics Biomedical.
Tejal Desai is a Professor and Chair of the Department of Bioengineering and Therapeutic Sciences at University of California, San Francisco and head of the Therapeutic Micro and Nanotechnology Laboratory. Desai is an acknowledged world leader in therapeutic microscale and nanoscale technologies and is at the forefront of engineering the next generation of drugs, using the tools of semiconductor manufacturing from Silicon Valley to make miniscule medical devices that deliver a drug or multiple drugs directly to specific areas of concern. Results from her lab include the use of silicon nanowire coated silica beads as adhesive drug-delivery vehicles, especially to the human gut, the micro/nanoscale cage or biocapsule for controlled drug delivery, and nanostructured thin-film devices for controlled ocular drug delivery. An elected fellow of the American Institute of Medical and Biological Engineering (AIMBE) the Biomedical Engineering Society, and the National Academy of Medicine, Desai is also a recipient of the prestigious Paul Dawson Biotechnology Award from the American Association of Colleges of Pharmacy. She was selected as one of the “Brilliant 10” Top Scientists in the Nation by Popular Science, received the Visionary Science Award from the BioMEMS and Nanotechnology Society, and the Global Indus Technovator Award from MIT.
Ann Beal Salamone is President of Rochal Industries, which is a global leader in commercializing technology innovations in polymer, antimicrobial and biological systems. She has developed products for electronics, water purification, personal care and healthcare and has invested in, and served on, the boards for several entrepreneurial companies as well as co-founded six companies. During her tenure as Vice President of EDC (a South Florida science & technology incubator), EDC’s clients increased aggregate revenues by more than $98 million, raised more than $74 million in outside funding, and created 5,013 jobs. She was elected Chairman of the American Chemical Society’s Polymer Division (8,000 members) and is a co-founder of the Intersociety Polymer Education Council which has provided hands-on in-services to over 500,000 K-12 science teachers since 1991. She is an Inaugural Fellow of ACS and a Fellow of AIMBE, the recipient of the 2002 Crystal Slipper Award “Executive Woman of the Year” and a recipient of the 2011 Healthcare Businesswomen’s Association LEAD Award. Salamone serves as Vice Chair of the BioMed SA Board of Directors, a member of the UTSA Biomedical Engineering Advisory Board, and a member of three UT Health-San Antonio Advisory Boards related to translational clinical science and community health. Salamone was elected to the National Academy of Engineering in 2016 “for development of materials for biomedical applications, personal care, electronics, and water purification.”
Dr. Molly Shoichet holds the Tier 1 Canada Research Chair in Tissue Engineering and is University Professor of Chemical Engineering & Applied Chemistry, Chemistry and Biomaterials & Biomedical Engineering at the University of Toronto. She is an expert in the study of Polymers for Drug Delivery & Regeneration which are materials that promote healing in the body. Dr. Shoichet has published over to 575 papers, patents and abstracts and has given over 350 lectures worldwide. She currently leads a laboratory of 32 researchers and has graduated 157 researchers over the past 22 years. Dr. Shoichet co-founded three spin-off companies, is actively engaged in translational research and science outreach. Dr. Shoichet is the recipient of many prestigious distinctions and the only person to be a Fellow of Canada’s 3 National Academies: Canadian Academy of Sciences of the Royal Society of Canada, Canadian Academy of Engineering, and Canadian Academy of Health Sciences. Dr. Shoichet won the L’Oréal-UNESCO For Women in Science Award for North America in 2015. Dr. Shoichet holds the Order of Canada, Canada’s highest civilian honor and the Order of Ontario, Ontario’s highest honor. She is a Fellow of the American Association for the Advancement of Science. In 2013, her contributions to Canada’s innovation agenda and the advancement of knowledge were recognized with the QEII Diamond Jubilee Award. In 2014, she was given the University of Toronto’s highest distinction, University Professor, a distinction held by less than 2% of the faculty. She is an elected member of the National Academy of Engineering, the American Institute for Medical and Biological Engineering and winner of the Killam Prize in Engineering in 2017. In 2018, Dr. Shoichet was named Chief Scientist for the province of Ontario.